Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug;12(8):1193-6.
doi: 10.1513/AnnalsATS.201412-577OC.

Indolent, Potentially Inconsequential Lung Cancers in the Pittsburgh Lung Screening Study

Prashanth M Thalanayar  1 , Nejat Altintas  2 , Joel L Weissfeld  3 , Carl R Fuhrman  4 , David O Wilson  5
Affiliations

Indolent, Potentially Inconsequential Lung Cancers in the Pittsburgh Lung Screening Study

Prashanth M Thalanayar et al. Ann Am Thorac Soc. 2015 Aug.

Abstract

Rationale: The finding of indolent, potentially inconsequential cancers (overdiagnosis) is inherent to cancer screening in general, and there is a growing body of literature about this concept in lung cancer screening.

Objectives: We report on indolent, potentially inconsequential lung cancers in the Pittsburgh Lung Screening Study (PLuSS) population screened for lung cancer with annual low-dose computed tomography.

Methods: We identified 93 subjects with screen-detected prevalence cancers in PLuSS. We defined indolent, potentially inconsequential cancers as stage I prevalence lung cancer cases that had volumetric doubling time >400 days (when available) and maximal standardized uptake value max on positron emission tomography (PET) scan ≤1 (when available).

Measurements and main results: Approximately 18.5% (n = 17) of all 93 screen-detected prevalence lung cancers in PLuSS were indolent, potentially inconsequential cancers. All such cancers except for one were adenocarcinomas by histology. Median tumor size of such cancers at the time of final diagnosis was 10 mm (range, 7-22 mm). Median doubling time was significantly longer in this group when compared with the rest of the prevalence stage 1 cancers (752 vs. 284.5 d).

Conclusions: Although the precise definitions may vary, the existence of indolent, potentially inconsequential cancers in low-dose computed tomography lung cancer screening is real. Clinicians involved in managing patients with low-dose computed tomography-detected slow-growing nodules, especially with a standardized uptake value ≤1 on PET scan, should consider the possibility of indolent, potentially inconsequential cancer in the longitudinal management of these nodules.

Keywords: PLuSS; low-dose computed tomography; lung cancer screening.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Workflow of screen-detected lung cancer using indolence criteria. PLuSS = Pittsburgh Lung Screening Study.
See this image and copyright information in PMC

Comment in

References

    1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395–409. - PMC - PubMed
    1. Yankelevitz DF, Kostis WJ, Henschke CI, Heelan RT, Libby DM, Pasmantier MW, Smith JP. Overdiagnosis in chest radiographic screening for lung carcinoma: frequency. Cancer. 2003;97:1271–1275. - PubMed
    1. Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Tazelaar HD, Mandrekar JN. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology. 2007;242:555–562. - PubMed
    1. Veronesi G, Maisonneuve P, Bellomi M, Rampinelli C, Durli I, Bertolotti R, Spaggiari L. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med. 2012;157:776–784. - PubMed
    1. Patz EF, Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, Chiles C, Black WC, Aberle DR NLST Overdiagnosis Manuscript Writing Team. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014;174:269–274. - PMC - PubMed

Publication types